Bailey-Freely v. Abbott Laboratories et al
Kimberly Bailey-Freely |
Abbott Laboratories, Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., The Procter & Gamble Distributing LLC F/K/A The Procter & Gamble Distributing Co., Takeda Pharmaceuticals USA, Inc., Novartis Vaccines and Diagnostics, Inc., Astrazeneca LP, Novartis Consumer Health, Inc., Takeda Pharmaceutical Company Limited, Novartis Pharmaceuticals Corporation, The Procter & Gamble Company, AstraZeneca Pharmaceuticals LP, Novartis Institutes For Biomedical Research, Inc., Novartis Corporation, Glaxosmithkline Consumer Healthcare Holdings (US) LLC, The Procter & Gamble Manufacturing Company, Merck & Co., Inc. D/B/A Merck, Sharp & Dohme Corporation and Takeda Pharmaceuticals America, Inc. |
1:2020cv07586 |
December 19, 2020 |
US District Court for the Northern District of Illinois |
Andrea R Wood |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 |
Both |
Docket Report
This docket was last retrieved on January 6, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
ELECTRONIC Acknowledgement of case transferred to the District of New Jersey [LIVE] as case 2:21-cv-00216, filed 01/06/2021. (bg, ) |
Filing 10 MINUTE entry before the Honorable Andrea R. Wood: The case having been transferred to the District of New Jersey, the telephonic status hearing and the parties' obligation to file a joint status report are stricken. Mailed notice (dal, ) |
Filing 9 TRANSFERRED to the District Court for the District of New Jersey, Newark Division the Electronic Record. (mc, ) |
Filing 7 MINUTE entry before the Honorable Andrea R. Wood: Telephonic initial status conference set for 1/21/2021 at 10:15 AM. To ensure public access to court proceedings, members of the public and media may call in to listen to telephonic hearings. The call-in number is (888) 557-8511 and the access code is 3547847. Counsel of record will receive an email 30 minutes prior to the start of the telephonic hearing with instructions to join the call. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court-issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. The parties are directed to meet and conduct a planning conference pursuant to Federal Rule of Civil Procedure 26(f). At least seven days before the initial status hearing, the parties shall file a joint written status report, not to exceed five pages in length. The initial status report shall provide the information described on the Court's website at www.ilnd.uscourts.gov under District Judges, Judge Andrea R. Wood, Initial Status Conference. Mailed notice (dal, ) |
Filing 8 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to United States District Court for the District of New Jersey. Signed by the Unassigned on 1/4/2021. Mailed notice(mc, ) |
Civil Case Terminated pursuant to MDL 2789 Conditional Transfer Order filed 1/4/2021 (mc, ) |
Filing 6 MAILED Notice of Removal letter to counsel of record. (mc, ) |
CASE ASSIGNED to the Honorable Andrea R. Wood. Designated as Magistrate Judge the Honorable Sunil R. Harjani. Case assignment: Random assignment. (cp, ) |
Filing 5 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by Sherry Ann Knutson (Knutson, Sherry) |
Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. (Hemmings, James) |
Filing 3 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by James R M Hemmings (Hemmings, James) |
Filing 2 CIVIL Cover Sheet (Hemmings, James) |
Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2019-L-006058) filed by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. Filing fee $ 402, receipt number 0752-17761736. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Hemmings, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.